M&A / Deals Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant Pharmaceutical TechnologyVivani's NanoPortal technology delivers medication steadily over long periods of time.Metabolic & GLP-1Read full story pharminent July 8, 2026 (Last updated: July 15, 2026) Pharmaceutical Technology Vivani’s NanoPortal technology delivers medication steadily over long periods of time. Metabolic & GLP-1 Read full story Post navigation Previous: Novartis Pays $1.1B Upfront for Myricx Bio ADC PlatformNext: AstraZeneca bets up to $1.9B in respiratory disease collab with Sino Biopharmaceutical Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026